Novel compounds of the formula (I), in which R.sup.1, R.sup.2, R.sup.3, X and Y have the meaning indicated in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors. ##STR00001##